Uterine fibroid embolization (UFE) is covered by most major health insurance plans in the United States, including Medicare, when it’s deemed medically necessary. The procedure is well-established, with clinical evidence dating back to 1995, and major insurers like Aetna, UnitedHealthcare, AmeriHealth, and Blue Cross Blue Shield all have coverage policies for it. That said, approval isn’t automatic. Your insurer will look at specific clinical criteria before signing off.
What Insurers Require for Approval
Insurance companies cover UFE when you meet their definition of “medical necessity,” which generally means you have symptomatic fibroids and a legitimate reason for choosing embolization over other options. AmeriHealth, for example, considers UFE appropriate when any of the following apply: anesthesia poses a high surgical risk, you have medical reasons that rule out hysterectomy (such as morbid obesity), hormonal therapy is contraindicated or has already failed, you have a condition called hydronephrosis, or you simply wish to avoid hysterectomy.
That last point is significant. Wanting to keep your uterus is, on its own, an accepted reason for coverage at many insurers. You don’t necessarily need to have failed every other treatment first, though most clinical guidelines recommend trying medical management before pursuing more invasive therapies.
UnitedHealthcare’s policy is similarly broad, classifying UFE as “proven and medically necessary” for symptomatic fibroids. However, UnitedHealthcare specifically excludes coverage when the purpose is preserving the ability to have children, citing insufficient evidence for that use. Aetna takes a similar stance, listing women who may wish to become pregnant as a contraindication. This is one of the more important distinctions to be aware of if future fertility is part of your planning.
Situations That Can Lead to Denial
Even though UFE is broadly covered, certain clinical situations will result in a denial. Insurers generally will not cover UFE if you are postmenopausal and your fibroids are growing (because rapid growth could signal a more serious condition), if you have an active pelvic infection or malignancy, or if you have a history of pelvic radiation, chronic pelvic infections, or severe endometriosis.
Timing also matters. If you’ve recently taken a hormone medication called a GnRH agonist to shrink fibroids, insurers may require a waiting period of at least six weeks after stopping the medication before UFE can be performed. The procedure may not work effectively if done too soon after that type of hormonal treatment.
Medicare and Medicaid Coverage
Medicare covers therapeutic embolization, the broader category that includes UFE, when it is “reasonable and necessary for the individual patient.” There is no separate national coverage determination that singles out UFE for special restrictions. In practice, this means Medicare beneficiaries can access UFE under the same general medical necessity standards that apply to other covered procedures. Medicaid coverage varies by state, so you’ll need to check with your state’s Medicaid program for specifics.
The Pre-Authorization Process
Most insurers require pre-authorization before you can schedule UFE. This means your doctor’s office submits documentation to your insurance company proving the procedure is medically appropriate for your case. The typical documentation includes imaging results (usually an ultrasound or MRI confirming the presence of fibroids), a record of your symptoms such as heavy bleeding or pelvic pressure, and notes showing what treatments you’ve already tried.
The American College of Obstetricians and Gynecologists recommends that women considering UFE have a thorough evaluation with an OB-GYN before the procedure, which also helps build the documentation your insurer needs. The procedure itself is performed by an interventional radiologist, but having that gynecologic evaluation on file strengthens the case for approval.
Strong Clinical Evidence Supports Coverage
One reason UFE enjoys broad insurance coverage is the weight of evidence behind it. The American College of Radiology rates UFE as “Usually Appropriate” for reproductive-age patients with symptomatic fibroids, whether or not they want to preserve fertility (though individual insurer policies on fertility preservation vary, as noted above). Studies show UFE causes an average decrease in fibroid size of more than 50% at five years. Randomized controlled trials have found it equally effective as myomectomy (surgical fibroid removal) at reducing heavy menstrual bleeding at four years, with shorter hospital stays, lower risk of blood transfusion, and significantly lower rates of new fibroid formation.
What You’ll Pay Out of Pocket
The total cost of UFE in the United States ranges from roughly $8,000 to $15,000 or more without insurance, depending on where you live. Regional averages break down roughly as follows:
- Midwest: $7,500 to $13,000
- South: $8,500 to $14,000
- West Coast: $9,000 to $16,000
- Northeast: $10,000 to $18,000
With insurance, most patients pay between $1,000 and $5,000 out of pocket. That range covers your deductible, copays, pre-procedure consultations, and follow-up visits. The facility fee, which covers the procedure room and equipment, is the largest component of the total bill. Hospitals generally charge more than outpatient centers for the same procedure, so where it’s performed can meaningfully affect your share of the cost.
Steps to Confirm Your Coverage
Because every plan has different deductibles, copay structures, and medical necessity definitions, the most reliable way to confirm coverage is to call the member services number on your insurance card and ask specifically about uterine artery embolization or uterine fibroid embolization. The CPT billing code your doctor’s office will use is 37210, which can help the representative look up the right policy. Ask whether pre-authorization is required, what documentation they need, and whether there are any restrictions on where the procedure can be performed (hospital versus outpatient facility).
If your initial request is denied, you have the right to appeal. Denials sometimes happen because of incomplete documentation rather than a true coverage exclusion, so having your interventional radiologist and OB-GYN submit additional clinical notes can often resolve the issue.